Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionMarathon Capital Management
Latest Disclosed Ownership4,705 shares
Latest Disclosed Value $ 483,088
Marathon Capital Management ownership in ABL / Abbott Laboratories

On May 14, 2026 - Marathon Capital Management filed a 13F-HR form disclosing ownership of 4,705 shares of Abbott Laboratories (DE:ABL) valued at $417,898 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 4,705 shares of Abbott Laboratories. This represents a change in shares of 0.00% during the quarter. The current value of the position is $353,910 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 4,705 0 0.00 483 -18.00 0.1085
2026-01-29 2025-12-31 13F ABBOTT LABS COM 002824100 4,705 -50 -1.05 590 -7.39 0.1269
2025-11-14 2025-09-30 13F ABBOTT LABS COM 002824100 4,755 -10 -0.21 637 -1.85 0.1457
2025-08-14 2025-06-30 13F ABBOTT LABS COM 002824100 4,765 -50 -1.04 648 1.57 0.1651
2025-05-15 2025-03-31 13F ABBOTT LABS COM 002824100 4,815 -24 -0.50 639 16.64 0.1701
2025-02-14 2024-12-31 13F ABBOTT LABS COM 002824100 4,839 0 0.00 547 -0.73 0.1367
2024-11-14 2024-09-30 13F ABBOTT LABS COM 002824100 4,839 0 0.00 552 9.76 0.1338
2024-08-14 2024-06-30 13F ABBOTT LABS COM 002824100 4,839 -12 -0.25 503 -8.89 0.1281
2024-05-15 2024-03-31 13F ABBOTT LABS COM 002824100 4,851 15 0.31 551 3.57 0.1316
2024-02-14 2023-12-31 13F/A-1 ABBOTT LABS COM 002824100 4,836 -50 -1.02 532 12.47 0.1338
2024-02-08 2023-12-31 13F ABBOTT LABS COM 002824100 4,836 -50 532 0.1338
2023-11-14 2023-09-30 13F ABBOTT LABS COM 002824100 4,886 1 0.02 473 -11.09 0.1191
2023-08-15 2023-06-30 13F/A-1 ABBOTT LABS COM 002824100 4,885 0 0.00 533 7.69 0.1315
2023-08-14 2023-06-30 13F ABBOTT LABS COM 002824100 4,885 0 533 0.1290
2023-05-12 2023-03-31 13F ABBOTT LABS COM 002824100 4,885 0 0.00 495 -7.84 0.1217
2023-02-14 2022-12-31 13F ABBOTT LABS COM 002824100 4,885 0 0.00 536 13.32 0.1478
2022-11-14 2022-09-30 13F Abbott Laboratories COM 002824100 4,885 -55 -1.11 473 -11.92 0.1351
2022-08-12 2022-06-30 13F Abbott Laboratories COM 002824100 4,940 4,940 537 0.1735
2022-05-13 2022-03-31 13F Abbott Laboratories COM 002824100 0 -4,884 -100.00 0 -100.00
2022-02-09 2021-12-31 13F Abbott Laboratories COM 002824100 4,884 -745 -13.24 687 3.15 0.1610
2021-11-15 2021-09-30 13F Abbott Laboratories COM 002824100 5,629 626 12.51 666 14.83 0.1512
2021-08-16 2021-06-30 13F Abbott Laboratories COM 002824100 5,003 0 0.00 580 -3.17 0.1343
2021-05-14 2021-03-31 13F Abbott Laboratories COM 002824100 5,003 275 5.82 599 15.86 0.1579
2021-02-08 2020-12-31 13F Abbott Laboratories COM 002824100 4,728 -266 -5.33 517 -4.79 0.1524
2020-11-16 2020-09-30 13F Abbott Laboratories COM 002824100 4,994 -89 -1.75 543 16.77 0.1977
2020-08-14 2020-06-30 13F Abbott Laboratories COM 002824100 5,083 0 0.00 465 15.96 0.1786
2020-05-15 2020-03-31 13F Abbott Laboratories COM 002824100 5,083 -54 -1.05 401 -10.09 0.1841
2020-02-14 2019-12-31 13F Abbott Laboratories COM 002824100 5,137 1,976 62.51 446 68.94 0.1517
2019-11-13 2019-09-30 13F Abbott Laboratories COM 002824100 3,161 1 0.03 264 -0.38 0.1065
2019-07-25 2019-06-30 13F Abbott Laboratories COM 002824100 3,160 -11 -0.35 265 4.74 0.1081
2019-05-15 2019-03-31 13F Abbott Laboratories COM 002824100 3,171 -65 -2.01 253 8.12 0.1130
2019-02-07 2018-12-31 13F Abbott Laboratories COM 002824100 3,236 3,236 234 0.1162
2016-02-12 2015-12-31 13F Abbott Laboratories COM 002824100 0 -6,568 -100.00 0 -100.00
2015-11-12 2015-09-30 13F Abbott Laboratories COM 002824100 6,568 0 0.00 264 -18.01 0.1341
2015-08-11 2015-06-30 13F Abbott Laboratories COM 002824100 6,568 63 0.97 322 6.98 0.1485
2015-05-06 2015-03-31 13F Abbott Laboratories COM 002824100 6,505 494 8.22 301 11.07 0.1334
2015-02-09 2014-12-31 13F Abbott Laboratories COM 002824100 6,011 0 0.00 271 8.40 0.2497
2014-10-30 2014-09-30 13F Abbott Laboratories COM 002824100 6,011 0 0.00 250 1.63 0.2253
2014-08-08 2014-06-30 13F Abbott Laboratories COM 002824100 6,011 0 0.00 246 6.49 0.1979
2014-04-30 2014-03-31 13F Abbott Laboratories COM 002824100 6,011 100 1.69 231 1.76 0.1736
2014-01-28 2013-12-31 13F Abbott Laboratories COM 002824100 5,911 5,911 227 0.1638
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.